BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2390636)

  • 1. Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
    Hansen JA; Anasetti C; Beatty PG; Martin PJ; Sanders JE; Storb R; Thomas ED
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():108-11. PubMed ID: 2390636
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation and graft-versus-host disease.
    Powles RL
    Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplantation from donors other than HLA identical siblings. What have we learned from previous experiences?
    Hervé P; Cahn JY; Tiberghien P; Racadot E; Plouvier E; Flesch M; Wijdenes J
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():112-4. PubMed ID: 2390637
    [No Abstract]   [Full Text] [Related]  

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies.
    Kapoor N; Copelan EA; Klein J; Tutschka PJ
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():153-5. PubMed ID: 2697430
    [No Abstract]   [Full Text] [Related]  

  • 7. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
    Aschan J; Ringdén O; Andström E; Ljungman P; Lönnqvist B; Remberger M
    Bone Marrow Transplant; 1994 Jul; 14(1):79-87. PubMed ID: 7951124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K
    Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunobiology of bone marrow transplantation as treatment for hematologic malignancies.
    Champlin R
    Transplant Proc; 1991 Aug; 23(4):2123-7. PubMed ID: 1871828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.
    Anasetti C; Beatty PG; Storb R; Martin PJ; Mori M; Sanders JE; Thomas ED; Hansen JA
    Hum Immunol; 1990 Oct; 29(2):79-91. PubMed ID: 2249952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gluckman E; Reiffers J; Vernant JP; Jouet JP; Harrousseau JL; Fiere D; Bacigalupo A; Frassoni F; Gorin NC
    Bone Marrow Transplant; 1996 Nov; 18(5):921-9. PubMed ID: 8932846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
    Kolb HJ; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas RJ; Mempel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):421-5. PubMed ID: 2480284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia.
    Passweg JR; Tiberghien P; Cahn JY; Vowels MR; Camitta BM; Gale RP; Herzig RH; Hoelzer D; Horowitz MM; Ifrah N; Klein JP; Marks DI; Ramsay NK; Rowlings PA; Weisdorf DJ; Zhang MJ; Barrett AJ
    Bone Marrow Transplant; 1998 Jan; 21(2):153-8. PubMed ID: 9489632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociating graft-vs-host disease from the graft-vs-leukemia effect of allogeneic T cells: the potential role of IL-2.
    Sykes M
    Bone Marrow Transplant; 1992; 10 Suppl 1():1-4. PubMed ID: 1521080
    [No Abstract]   [Full Text] [Related]  

  • 19. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.
    DeGast GC; Mickelson EM; Beatty PG; Amos D; Sullivan KM; Schoch HG; Thomas ED; Hansen JA
    Bone Marrow Transplant; 1992 Feb; 9(2):87-90. PubMed ID: 1533333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.